Limited English Proficiency Not Linked to Sepsis Mortality Overall
By Elana Gotkine HealthDay Reporter
FRIDAY, Jan. 5, 2024 -- Limited English proficiency (LEP) is not associated with overall sepsis mortality, but in a subgroup analysis, it was associated with mortality among those identifying as non-Hispanic White, according to a study published online Jan. 4 in JAMA Network Open.
Neha P. Limaye, M.D., M.P.H., from Mount Sinai Hospital in New York City, and colleagues examined the association between LEP and inpatient mortality among patients with sepsis in a retrospective cohort study. A total of 2,709 patients met the inclusion criteria; 12.1 percent had LEP.
The researchers found that unadjusted mortality included 19.6 and 21.1 percent of 2,382 and 327 patients with EP and LEP, respectively, with no significant difference seen in the odds of mortality (odds ratio, 1.12; 95 percent confidence interval, 0.88 to 1.42). Among the non-Hispanic White subgroup, however, the odds of inpatient mortality were significantly higher for patients with LEP (odds ratio, 1.76; 95 percent confidence interval, 1.41 to 2.21) when stratified by race and ethnicity. This difference was also significant in adjusted analyses (adjusted odds ratio, 1.56; 95 percent confidence interval, 1.02 to 2.39). In the racial and ethnic-minority subgroup, no significant differences were found in inpatient mortality between LEP and EP (adjusted odds ratio, 0.91; 95 percent confidence interval, 0.56 to 1.48).
"The inequities found here may exist across other diagnoses as well," the authors write. "Most importantly, these findings call for targeted interventions to promote language equity, as the Institute of Medicine initially called for in 2004."
Several authors disclosed ties to the pharmaceutical industry.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-01-06 02:15
Read more
- Cutaneous Malignant Melanoma Incidence Increasing Among the Elderly
- Palleon Pharmaceuticals Presents Results from the Phase 1/2 GLIMMER-01 Trial of E-602 in Combination with Cemiplimab in Patients with Solid Tumors at the Society for Immunotherapy of Cancer (SITC) Annual Meeting
- Money, Education Helps Determine Your Odds for Dementia
- EPA Finalizes Tough New Standards on Lead Paint Dust
- 1 in 4 U.S. Adults Suspect They Have Undiagnosed ADHD
- Current Tobacco Use Declining in U.S. Youth in 2024
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions